solution for injection/infusion

DRUG2 trials

Sponsors

Bristol-Myers Squibb Services Unlimited Company, Centre Hospitalier De Versailles

Conditions

Pan tumorRelapsed/refractory T-cell Acute Lymphoblastic Leukemia

Phase 2

Pan Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS sponsored Trials Investigating Nivolumab and Other Cancer Therapies

RecruitingCTIS2023-506914-32-00

Bristol-Myers Squibb Services Unlimited CompanyPan tumor

Start: 2020-05-05Target: 307Updated: 2026-01-19

A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL

Not yet recruitingCTIS2024-516570-30-00

Centre Hospitalier De VersaillesRelapsed/refractory T-cell Acute Lymphoblastic Leukemia

Target: 12Updated: 2026-05-29